PT1390525E - Piruvato-quinase como uma nova molécula alvo - Google Patents
Piruvato-quinase como uma nova molécula alvo Download PDFInfo
- Publication number
- PT1390525E PT1390525E PT02748716T PT02748716T PT1390525E PT 1390525 E PT1390525 E PT 1390525E PT 02748716 T PT02748716 T PT 02748716T PT 02748716 T PT02748716 T PT 02748716T PT 1390525 E PT1390525 E PT 1390525E
- Authority
- PT
- Portugal
- Prior art keywords
- pyruvate
- kinase
- target molecule
- novel target
- target
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01112601 | 2001-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1390525E true PT1390525E (pt) | 2008-11-25 |
Family
ID=8177529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02748716T PT1390525E (pt) | 2001-05-23 | 2002-05-23 | Piruvato-quinase como uma nova molécula alvo |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040152648A1 (pt) |
EP (2) | EP1390525B8 (pt) |
AT (1) | ATE404691T1 (pt) |
AU (1) | AU2002319180B2 (pt) |
CA (1) | CA2448165A1 (pt) |
DE (1) | DE60228233D1 (pt) |
DK (1) | DK1390525T3 (pt) |
ES (1) | ES2312595T3 (pt) |
PT (1) | PT1390525E (pt) |
WO (1) | WO2002095063A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004016646A2 (en) * | 2002-08-12 | 2004-02-26 | Amynon Bio Tech Gmbh | Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) |
WO2004058153A2 (en) * | 2002-12-20 | 2004-07-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
DE10356218A1 (de) * | 2003-12-03 | 2005-06-30 | Bayer Cropscience Ag | Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Pyruvatkinasen aus Pilzen |
WO2006055880A2 (en) * | 2004-11-16 | 2006-05-26 | Genzyme Corporation | Diagnostic pkm2 methods and compositions |
US20060166236A1 (en) * | 2004-12-15 | 2006-07-27 | Chong-Sheng Yuan | Allosteric enzyme coupled immunoassay (AECIA) |
US8552050B2 (en) * | 2007-08-16 | 2013-10-08 | Beth Israel Deaconess Medical Center | Activators of pyruvate kinase M2 and methods of treating disease |
US8841305B2 (en) | 2008-10-09 | 2014-09-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Activators of the human pyruvate kinase M2 receptor |
CA2758071C (en) | 2009-04-06 | 2018-01-09 | Agios Pharmaceuticals, Inc. | Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use |
PL2427441T3 (pl) | 2009-05-04 | 2017-06-30 | Agios Pharmaceuticals, Inc. | Aktywatory PKM2 do stosowania w leczeniu raka |
TWI598337B (zh) | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
JP5764555B2 (ja) | 2009-06-29 | 2015-08-19 | アジオス ファーマシューティカルズ, インコーポレイテッド | 治療組成物および関連する使用方法 |
EP3561077B1 (en) | 2009-10-21 | 2022-12-21 | Les Laboratoires Servier | Methods for cell-proliferation-related disorders |
WO2011050211A2 (en) | 2009-10-21 | 2011-04-28 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
WO2011109823A1 (en) | 2010-03-05 | 2011-09-09 | The Trustees Of Columbia University In The City Of New York | Inhibitory rnas to rna binding proteins hnrnpa1, hnrnpa2 and ptb and uses thereof |
EP2563761A1 (en) | 2010-04-29 | 2013-03-06 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Activators of human pyruvate kinase |
US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
WO2012088314A1 (en) | 2010-12-21 | 2012-06-28 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
KR101873543B1 (ko) | 2011-05-03 | 2018-07-02 | 아지오스 파마슈티컬스 아이엔씨. | 치료에 사용하기 위한 피루베이트 키나아제 활성제 |
EP3307271B1 (en) | 2015-06-11 | 2023-09-13 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
CA3024181C (en) | 2017-03-20 | 2023-06-13 | Forma Therapeutics, Inc. | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators |
EP3852791B1 (en) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Activating pyruvate kinase r |
MA53668A (fr) | 2018-09-19 | 2021-09-15 | Forma Therapeutics Inc | Traitement de la drépanocytose avec un composé activant la pyruvate kinase r |
US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821254A (en) * | 1995-02-17 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
WO1998035032A2 (en) * | 1997-02-11 | 1998-08-13 | The Regents Of The University Of California | Methods of inducing cell cycle stasis |
US7074895B2 (en) * | 1997-08-21 | 2006-07-11 | Quark Biotech, Inc. | Sequences characteristic of hypoxia-regulated gene transcription |
US5948628A (en) * | 1997-09-05 | 1999-09-07 | The Board Of Regents Of The University Of Oklahoma | Methods of screening for compounds which mimic galectin-1 |
US6458538B1 (en) * | 1999-12-14 | 2002-10-01 | Ptc Therapeutics, Inc. | Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay |
-
2002
- 2002-05-23 ES ES02748716T patent/ES2312595T3/es not_active Expired - Lifetime
- 2002-05-23 WO PCT/EP2002/005684 patent/WO2002095063A1/en active IP Right Grant
- 2002-05-23 CA CA002448165A patent/CA2448165A1/en not_active Abandoned
- 2002-05-23 EP EP02748716A patent/EP1390525B8/en not_active Expired - Lifetime
- 2002-05-23 EP EP08014232A patent/EP1990422A1/en not_active Withdrawn
- 2002-05-23 AT AT02748716T patent/ATE404691T1/de not_active IP Right Cessation
- 2002-05-23 DE DE60228233T patent/DE60228233D1/de not_active Expired - Lifetime
- 2002-05-23 AU AU2002319180A patent/AU2002319180B2/en not_active Ceased
- 2002-05-23 PT PT02748716T patent/PT1390525E/pt unknown
- 2002-05-23 DK DK02748716T patent/DK1390525T3/da active
- 2002-05-23 US US10/478,679 patent/US20040152648A1/en not_active Abandoned
-
2007
- 2007-06-29 US US11/771,462 patent/US20080021116A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1390525A1 (en) | 2004-02-25 |
WO2002095063A1 (en) | 2002-11-28 |
US20080021116A1 (en) | 2008-01-24 |
EP1990422A1 (en) | 2008-11-12 |
CA2448165A1 (en) | 2002-11-28 |
DE60228233D1 (de) | 2008-09-25 |
EP1390525B1 (en) | 2008-08-13 |
EP1390525B8 (en) | 2009-03-04 |
ES2312595T3 (es) | 2009-03-01 |
ATE404691T1 (de) | 2008-08-15 |
DK1390525T3 (da) | 2008-12-08 |
US20040152648A1 (en) | 2004-08-05 |
AU2002319180B2 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1390525E (pt) | Piruvato-quinase como uma nova molécula alvo | |
IL202688A0 (en) | Novel use of a compound for treating diabetic neuropathic pain | |
MXPA03010232A (es) | Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central. | |
IL176674A0 (en) | Fc region variants | |
HK1087628A1 (en) | Prodrugs of gaba analogs, compositions and uses thereof gaba | |
PL366590A1 (en) | Novel compounds as anti-inflammatorz, immunomodulatory and anti-proliferatory agents | |
SE0202838D0 (sv) | Chemical compounds | |
IL175770A0 (en) | Novel use of peptide compounds for treating central neuropathic pain | |
AU9475001A (en) | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes | |
GB0325956D0 (en) | Novel compounds | |
TW200505837A (en) | Novel compounds | |
TW200519075A (en) | Novel compounds | |
MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO1999061398A3 (en) | 24-hydroxyvitamin d, analogs and uses thereof | |
IL175762A0 (en) | Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease | |
BR0214230A (pt) | Compostos e processos de fabricação de compostos | |
WO2004076614A3 (de) | Humane nukleinsäuresequenzen aus prostatakarzinomen | |
WO2003102185A3 (en) | Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules | |
SE0101082D0 (sv) | Novel use | |
WO2003037257A3 (en) | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 | |
TW200505435A (en) | Treatment of ocular disorders | |
WO2003091243A8 (en) | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics | |
NO20033401L (no) | Kjemiske forbindelser | |
IL164536A (en) | Use of hydroxypyridone-derivatives in the preparation of pharmaceuticals for wound healing | |
AU2003249999A8 (en) | 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |